| Date | Time | Source | Headline | Symbol | Company |
| 10/24/2013 | 4:14PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 10/15/2013 | 4:37PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 10/04/2013 | 5:47PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 10/04/2013 | 5:38PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 10/02/2013 | 5:16PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/18/2013 | 11:23AM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 09/12/2013 | 4:19PM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/28/2013 | 8:00AM | PR Newswire (US) | Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Ophthalmic Compound Development Opportunity | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/16/2013 | 5:08PM | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/14/2013 | 5:53PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/12/2013 | 8:00AM | PR Newswire (US) | Imprimis Pharmaceuticals, Inc. Comments on Delay in Phase III Impracor™ Program | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 08/05/2013 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals, Inc. to Present at the Southern California Investor Conference on Thursday, August 8, 2013 at the I... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/23/2013 | 8:34AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/23/2013 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Bleeding and Clotting Disorder Functional Antibiotic Drug C... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/22/2013 | 8:30AM | PR Newswire (US) | Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; ... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/17/2013 | 1:17PM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/12/2013 | 7:00PM | Business Wire | Faruqi & Faruqi, LLP Launches An Investigation Against Imprimis Pharmaceuticals, Inc. (IMMY) For Potential Breaches Of Fiduci... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/12/2013 | 7:00PM | Business Wire | Faruqi & Faruqi, LLP Launches An Investigation Against Imprimis Pharmaceuticals, Inc. (IMMY) For Potential Breaches Of Fiduci... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/05/2013 | 5:24PM | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/01/2013 | 5:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/01/2013 | 5:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/01/2013 | 5:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/01/2013 | 5:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 07/01/2013 | 5:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/27/2013 | 1:33PM | PR Newswire (US) | Imprimis Pharmaceuticals, Inc. set to join Russell Microcap Index | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/17/2013 | 10:30AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/17/2013 | 8:00AM | PR Newswire (US) | Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property Assets from Buderer Drug Company | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 06/14/2013 | 1:57PM | PR Newswire (US) | Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New Y... | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/22/2013 | 6:01AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |
| 05/08/2013 | 5:46PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IMMY | Imprimis Pharmaceuticals, Inc. (delisted) |